Investor PresentationsThe Company continued to make presentations to European and North American investors during thequarter. These presentations have resulted in on market buying by investors, providing internationalsupport for the Company’s business development strategy.
Rights IssueTo advance the Company’s algae and medicinal cannabis projects through to positive cash generation,which is scheduled for the second half of 2019, the Company has lected to proceed with a rights issueto all shareholders to raise circa A$5m. The pricing, ratio and final amount to be raised under the rightsissue have yet to be determined.
The Company is currently in discussions to secure underwriting of the rights issue and will in the nearterm finalise the details of this offer to send to shareholders.
With the Company having been granted a license in Malta it has been decided to undertake a rightsissue to raise circa A$5.00M to fund the first phase of the Malta cannabis facility, the initial build outin Australia (post ODC issuing the licences) and expand capacity and oil extraction and refining facilitiesin Atlanta.”
And apart from the usual mistakes they don't seem to be aware of what year they are making claims for research refunds-will they restate it without some of teh many errors ?
*2 This funding is an advance on the expected ATO Tax refund that will be submitted in August 2019 and coversestimated eligible R & D expenditure for the 1st Quarter of 2019 financial year. The carrying amount from June 2018 wasfully repaid in December 2018 following the refund from the ATO relating to eligible R & D expenditure for the 2018financial year. A further $266,231 was advanced in January 2019 covering expenditure in October and November 2019.- Should this perhaps be 2018??
Does no mention of India plant tell us something? If all the zeros in the "product manufacturing" costs for previous quarter and next don't tell you something ???????
Now exactly where did the $ 90,000 income come from??
Yeah the TSX is really going to want these guys.
AEB Price at posting:
0.9¢ Sentiment: None Disclosure: Not Held